Trials / Completed
CompletedNCT02542501
Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) Analogues
A Prospective Post Marketing Non Interventional Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive LHRH Analogues and to Evaluate the Effect of LHRH Analogues on Lower Urinary Tract Symptoms (ANALUTS Study)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 470 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The intention of this study is to investigate how many patients with prostate cancer, planned to be treated with LHRH analogues without history of surgery or radiotherapy, are suffering from LUTS. In addition the effect of LHRH analogues on the improvement of theses primary LUTS symptoms over time will be investigated.
Conditions
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2018-07-21
- Completion
- 2018-07-21
- First posted
- 2015-09-07
- Last updated
- 2018-12-21
Locations
32 sites across 2 countries: Portugal, Spain
Source: ClinicalTrials.gov record NCT02542501. Inclusion in this directory is not an endorsement.